Geron reported $218.61M in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
Amgen USD 11.69B 2.5B Jun/2026
Bio Techne USD 2.11B 22.92M Jun/2026
Cassava Sciences USD 68.14M 6.26M Mar/2026
Cytokinetics USD -173.49M 653.08M Jun/2026
Exelixis USD 1.84B 91.99M Jun/2026
Genmab DKK 5.96B 275M Jun/2026
Geron USD 218.61M 10.49M Jun/2026
Gilead Sciences USD 11.74B 11.77B Jun/2026
Incyte USD 6.34B 721.58M Jun/2026
MacroGenics USD 42.87M 21.68M Jun/2026
Novartis USD 41.95B 3.02B Jun/2026
Novavax USD -190.71M 45.94M Jun/2026